<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34608192</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea.</ArticleTitle><Pagination><StartPage>19682</StartPage><MedlinePgn>19682</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19682</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-98990-x</ELocationID><Abstract><AbstractText>Few studies have investigated the factors associated with assisted ventilation use in amyotrophic lateral sclerosis (ALS) in western countries with a relatively small number of participants. This study aimed to evaluate the factors associated with assisted ventilation use using a large nationwide cohort covering the entire Korean population. We selected patients with primary or secondary diagnoses of ALS (ICD-10 code: G12.21) and a registration code for ALS (V123) in the rare intractable disease registration program. Covariates included in the analyses were age, sex, socioeconomic status and medical condition. Factors associated with non-invasive ventilation (NIV) and tracheostomy invasive ventilation (TIV) were evaluated. Logistic regression analyses were performed using odds ratios and 95% confidence intervals. In total, 3057 patients with ALS were enrolled. During the 6-year follow-up period, 1228 (40%) patients started using assisted ventilation: 956 with NIV and 272 with TIV. There was no significant difference in the assisted ventilation use according to sex, whereas different patterns of discrepancies were noted between the sexes: Females living in non-metropolitan areas showed decreased use of assisted ventilation, whereas high income levels showed a positive relationship with assisted ventilation use only in males. Patients aged&#x2009;&#x2265;&#x2009;70&#xa0;years showed decreased use of NIV. NIV use was more affected by socioeconomic status than TIV, whereas TIV showed a significant relationship with medical conditions such as nasogastric tube insertion and gastrostomy. We found that various factors, including age, socioeconomic status, and medical condition, were related with assisted ventilation use. Understanding the pattern of assisted ventilation use would help set optimal management strategies in patients with ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Seo Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Korea University Guro Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Han-Kyoul</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Traffic Injury Rehabilitation Research Institute, National Traffic Injury Rehabilitation Hospital, Yang-Pyeong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Mi Ji</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Computing, Yonsei University Graduate School, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Jee Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leigh</LastName><ForeName>Ja-Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul, Republic of Korea. jaho.leigh@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Traffic Injury Rehabilitation Research Institute, National Traffic Injury Rehabilitation Hospital, Yang-Pyeong, Republic of Korea. jaho.leigh@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. jaho.leigh@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34608192</ArticleId><ArticleId IdType="pmc">PMC8490422</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-98990-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-98990-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gil J, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur. J. Neurol. 2008;15:1245&#x2013;1251. doi: 10.1111/j.1468-1331.2008.02307.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02307.x</ArticleId><ArticleId IdType="pubmed">18973614</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Miller RG. NIPPV: a treatment for ALS whose time has come. Neurology. 2006;67:736&#x2013;737. doi: 10.1212/01.wnl.0000238978.69141.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000238978.69141.57</ArticleId><ArticleId IdType="pubmed">16966530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J. Neurol. Neurosurg. Psychiatry. 2020;91:285&#x2013;290. doi: 10.1136/jnnp-2019-322213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322213</ArticleId><ArticleId IdType="pubmed">31937581</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev. 2017;10:CD004427. doi: 10.1002/14651858.CD004427.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004427.pub4</ArticleId><ArticleId IdType="pmc">PMC6485636</ArticleId><ArticleId IdType="pubmed">28982219</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218&#x2013;1226. doi: 10.1212/WNL.0b013e3181bc0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelot-Panzini C, Bruneteau G, Gonzalez-Bermejo J. NIV in amyotrophic lateral sclerosis: the 'when' and 'how' of the matter. Respirology. 2019;24:521&#x2013;530. doi: 10.1111/resp.13525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13525</ArticleId><ArticleId IdType="pubmed">30912216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001;57:500&#x2013;504. doi: 10.1212/wnl.57.3.500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.57.3.500</ArticleId><ArticleId IdType="pubmed">11502920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, Lovitt S, Gowda N, Anderson F, Miller RG. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler. 2006;7:80&#x2013;85. doi: 10.1080/14660820500504587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820500504587</ArticleId><ArticleId IdType="pubmed">16753971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo, J., Hansen-Flaschen, J., Wileyto, E., Kawut, S. &amp; Elman, L. Baseline risk factors for use of non-invasive ventilation in a cohort of patients with amyotrophic lateral sclerosis in Respirology 44 (Wiley, 2017).</Citation></Reference><Reference><Citation>Chi&#xf2; A, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J. Neurol. Neurosurg. Psychiatry. 2012;83:377&#x2013;381. doi: 10.1136/jnnp-2011-300472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300472</ArticleId><ArticleId IdType="pubmed">22013242</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur. J. Neurol. 2010;17:1352&#x2013;1357. doi: 10.1111/j.1468-1331.2010.03036.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.03036.x</ArticleId><ArticleId IdType="pubmed">20443984</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Lapin BR, Pioro EP, Aboussouan LS. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology. 2019;93:e306&#x2013;e316. doi: 10.1212/wnl.0000000000007776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000007776</ArticleId><ArticleId IdType="pubmed">31182506</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JH, et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34(1311):e1317&#x2013;1319. doi: 10.1016/j.neurobiolaging.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.004</ArticleId><ArticleId IdType="pubmed">23088937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon MJ, et al. Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS. Neurobiol. Aging. 2012;33(1017):e1017&#x2013;1023. doi: 10.1016/j.neurobiolaging.2011.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.12.003</ArticleId><ArticleId IdType="pubmed">22244934</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, et al. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotroph Lateral Scler. Frontotemporal Degener. 2015;16:202&#x2013;208. doi: 10.3109/21678421.2014.999791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.999791</ArticleId><ArticleId IdType="pubmed">25646865</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Dharamshi C, Zinman L. Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses. Amyotroph Lateral Scler. Frontotemporal Degener. 2014;15:426&#x2013;432. doi: 10.3109/21678421.2014.932382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.932382</ArticleId><ArticleId IdType="pubmed">25025935</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S, et al. Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective. Amyotroph Lateral Scler. Frontotemporal Degener. 2015;16:58&#x2013;62. doi: 10.3109/21678421.2014.957322.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.957322</ArticleId><ArticleId IdType="pubmed">25285902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin, N. et al. Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Other Motor Neuron Disord5, 9&#x2013;15. 10.1080/14660820310017335 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15204018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH. Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs. 2011;25:1&#x2013;15. doi: 10.2165/11586000-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11586000-000000000-00000</ArticleId><ArticleId IdType="pubmed">21128691</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot K, Feneberg E, Scaber J, Thompson AG, Turner MR. Amyotrophic lateral sclerosis: the complex path to precision medicine. J. Neurol. 2018;265:2454&#x2013;2462. doi: 10.1007/s00415-018-8983-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8983-8</ArticleId><ArticleId IdType="pmc">PMC6182683</ArticleId><ArticleId IdType="pubmed">30054789</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun KY, et al. Epidemiology of ALS in Korea using nationwide big data. J. Neurol. Neurosurg. Psychiatry. 2019;90:395&#x2013;403. doi: 10.1136/jnnp-2018-318974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318974</ArticleId><ArticleId IdType="pmc">PMC6581156</ArticleId><ArticleId IdType="pubmed">30409890</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J. Fam. Pract. 2000;49:147&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">10718692</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon G-S, Choi E-S, Lee H-Y. Gender-related difference in the utilization of health care services by Korean adults. J. Korean Public Health Nurs. 2010;24:182&#x2013;196.</Citation></Reference><Reference><Citation>Moss AH, et al. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology. 1993;43:438&#x2013;443. doi: 10.1212/wnl.43.2.438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.43.2.438</ArticleId><ArticleId IdType="pubmed">8437718</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien MR, Clark D. Spirituality and/or religious faith: a means for coping with the effects of amyotrophic lateral sclerosis/motor neuron disease? Palliat Support Care. 2015;13:1603&#x2013;1614. doi: 10.1017/s1478951515000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1478951515000097</ArticleId><ArticleId IdType="pubmed">25851240</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink, J. H., Wokke, J. H., van der Wal, G., Vianney de Jong, J. M. &amp; van den Berg, L. H. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N. Engl. J. Med.346, 1638&#x2013;1644. 10.1056/NEJMsa012739 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12023997</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Guay MO. Spirituality and religiosity in supportive and palliative care. Curr. Opin. Support Palliat Care. 2014;8:308&#x2013;313. doi: 10.1097/spc.0000000000000079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/spc.0000000000000079</ArticleId><ArticleId IdType="pubmed">25029394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J. Neurol. Neurosurg. Psychiatry. 2009;80:84&#x2013;87. doi: 10.1136/jnnp.2008.149708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.149708</ArticleId><ArticleId IdType="pubmed">19091712</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro, R., Lo Re, M., Piccoli, T., Piccoli, F. &amp; La Bella, V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol. Scand.122, 217&#x2013;223. 10.1111/j.1600-0404.2009.01290.x (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS ONE. 2017;12:e0177555. doi: 10.1371/journal.pone.0177555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177555</ArticleId><ArticleId IdType="pmc">PMC5441602</ArticleId><ArticleId IdType="pubmed">28542233</ArticleId></ArticleIdList></Reference><Reference><Citation>Schepelmann K, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. 2010;257:15&#x2013;23. doi: 10.1007/s00415-009-5256-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5256-6</ArticleId><ArticleId IdType="pubmed">19629566</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur. J. Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlowitz DJ, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. J. Neurol. Neurosurg. Psychiatry. 2016;87:280&#x2013;286. doi: 10.1136/jnnp-2014-310055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-310055</ArticleId><ArticleId IdType="pubmed">25857659</ArticleId></ArticleIdList></Reference><Reference><Citation>Spittel S, et al. Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: utilization and survival rates in a cohort study over 12 years in Germany. Eur. J. Neurol. 2021;28:1160&#x2013;1171. doi: 10.1111/ene.14647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14647</ArticleId><ArticleId IdType="pubmed">33210770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami M, et al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990&#x2013;2010. J. Neurol. Sci. 2014;344:158&#x2013;164. doi: 10.1016/j.jns.2014.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.06.047</ArticleId><ArticleId IdType="pubmed">25017882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT, et al. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J. Epidemiol. 2013;23:35&#x2013;40. doi: 10.2188/jea.je20120119.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je20120119</ArticleId><ArticleId IdType="pmc">PMC3700231</ArticleId><ArticleId IdType="pubmed">23117224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, et al. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J. Neurol. Neurosurg. Psychiatry. 2010;81:1141&#x2013;1143. doi: 10.1136/jnnp.2009.175984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.175984</ArticleId><ArticleId IdType="pubmed">20660920</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JH, et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:e1317&#x2013;1319. doi: 10.1016/j.neurobiolaging.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.004</ArticleId><ArticleId IdType="pubmed">23088937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CP, et al. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol. Aging. 2012;33:2232. doi: 10.1016/j.neurobiolaging.2012.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.002</ArticleId><ArticleId IdType="pubmed">22673113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogaki K, et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:e2511&#x2013;2526. doi: 10.1016/j.neurobiolaging.2012.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.011</ArticleId><ArticleId IdType="pubmed">22727276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EJ, et al. Analysis of frontotemporal dementia, amyotrophic lateral sclerosis, and other dementia-related genes in 107 Korean patients with frontotemporal dementia. Neurobiol. Aging. 2018;72:e181&#x2013;186. doi: 10.1016/j.neurobiolaging.2018.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.031</ArticleId><ArticleId IdType="pubmed">30054184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>